- AVXL -2.45%
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call Transcript
Yahoo Finance · 2 hours ago
Open | 3.8800 |
High | 3.9199 |
Low | 3.7450 |
Mkt Cap | 320.37M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 3.8800 |
52 Wk. Low | 3.2500 |
52 Wk. High | 10.4500 |
Related stocks
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -8.62M | - |
Diluted EPS | -0.13 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.13 | - |
Q1 2024 | -$0.11 | -$0.13 |
Q4 2023 | -$0.14 | -$0.11 |
S&P 500^GSPC | 5,218.55+4.47 (+0.09%) |
Dow 30^DJI | 39,496.37+108.61 (+0.28%) |
Nasdaq^IXIC | 16,324.96-21.31 (-0.13%) |
Novavax, Inc.NVAX | 9.08+103.11% |
150.33+5.28% | |
17.78-1.28% |